Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1614 1615 1621 1626 1627 1672
This examiner grants 85% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18748207 | FOAMING COMPOSITIONS FOR CONTROLLING ARTHROPODS | Non-Final OA | The Procter & Gamble Company |
| 18541680 | METHODS AND COMPOSITIONS FOR PREDICTING AND PREVENTING RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18551809 | COMPOSITE DRUG PARTICLES AND USES THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18562616 | NUCLEIC ACID-CONJUGATED POLYMERIC NANOPARTICLES AND METHODS OF USE | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18734176 | CYCLIC DINUCLEOTIDES AS AGONISTS OF STIMULATOR OF INTERFERON GENE DEPENDENT SIGNALLING | Non-Final OA | Board of Regents, The University of Texas System |
| 18870026 | HAIR TREATMENT METHOD FOR LIMITING THE CALCIUM CONTENT OF THE HAIR | Non-Final OA | L'OREAL |
| 18919039 | NOVEL PHARMACEUTICAL FORMULATIONS | Non-Final OA | AUSPEX PHARMACEUTICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy